Pituicytes is an important cell type in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Pituicytes are specialized glial cells resident in the neurohypophysis (posterior pituitary gland) that play essential roles in regulating neurosecretory axon terminal function, hormone release, and maintaining the structural integrity of the pituitary-hypothalamic interface. These cells represent a critical component of the neuroendocrine system, serving as the primary glial element that interfaces between neuronal projections from the supraoptic and paraventricular nuclei and the perivascular space surrounding the posterior pituitary capillary plexus.
| Property | Value |
|---|---|
| Location | Neurohypophysis (posterior pituitary gland) |
| Region | Pars nervosa of the pituitary gland |
| Marker Genes | GFAP, S100B, Vimentin, AQP4, Nestin |
| Developmental Origin | Neuroectoderm, from hypothalamic tanycytes (radial glial lineage) |
| Cell Morphology | Stellar-shaped with multiple processes |
| Key Functions | Hormone release regulation, axon terminal support, barrier maintenance |
Pituicytes exhibit distinctive ultrastructural characteristics that distinguish them from other glial cell types. Their cell bodies measure approximately 10-15 μm in diameter and extend multiple long, branching processes that envelop neurosecretory axon terminals. These processes create a complex three-dimensional network that physically separates axon terminals from the perivascular space, forming what has been termed the "pituicyte barrier"[1].
The cytoplasm of pituicytes contains abundant intermediate filaments composed of glial fibrillary acidic protein (GFAP), which provides structural support and serves as a key phenotypic marker. Additionally, these cells express S100B calcium-binding protein, vimentin (particularly during development), and aquaporin-4 (AQP4) water channels that facilitate water movement during hormone secretion[2].
The posterior pituitary contains several morphologically distinct pituicyte subpopulations:
Type I (Dark) Pituicytes: Characterized by electron-dense cytoplasm, highly branched processes that extensively ensheath neurosecretory terminals, and abundant intermediate filaments. These cells are thought to represent a more active state associated with heightened process extension.
Type II (Light) Pituicytes: Display electron-lucent cytoplasm with fewer and simpler processes. They typically associate with smaller axon terminals and may represent a less active or different functional state.
Type III Pituicytes: Intermediate morphology between Type I and II, with moderate process complexity and cytoplasmic density.
Type IV (Degenerating) Pituicytes: Observed primarily in aged animals or under certain pathological conditions, characterized by cytoplasmic vacuolization and process retraction.
Pituicyte processes adopt highly dynamic configurations that can retract or extend in response to physiological demands. These processes typically terminate in endfoot structures that appose blood vessels (approximating the glial limitans) or ensheath individual neurosecretory axons. The extent of terminal ensheathment correlates with the functional state of the neurosecretory system—during periods of heightened hormonal demand, pituicyte processes may retract to permit greater terminalvascular contact and facilitate hormone release[3].
Pituicytes derive from the neuroectoderm, specifically from tanycytes—a specialized ependymal cell type lining the floor of the third ventricle. During embryonic development, tanycytes in the median eminence region proliferate and migrate ventrally to populate the developing posterior pituitary. This shared developmental lineage explains the continued phenotypic relationship between tanycytes and pituicytes in the adult brain[4].
In rodents, pituicyte maturation proceeds through the first three postnatal weeks, coinciding with the maturation of the hypothalamo-neurohypophyseal system. The establishment of pituicyte-axon terminal relationships correlates with the developmental acquisition of regulated hormone secretion capacity.
Pituicytes exhibit distinctive electrophysiological characteristics that reflect their glial nature:
Pituicytes demonstrate calcium waves and oscillations in response to:
These calcium dynamics can propagate to neighboring pituicytes through gap junctions, representing a form of glial communication that may coordinate collective responses to physiological demands[5].
The Kir4.1 channels expressed by pituicytes play a critical role in potassium buffering during neurosecretory activity. As neurosecretory terminals release hormone, extracellular potassium concentrations rise; pituicytes take up excess potassium, preventing toxic accumulation and maintaining optimal neuronal excitability.
Pituicytes serve as the primary regulator of neurosecretory axon terminal activity in the posterior pituitary. Their strategic positioning between terminals and the perivascular space enables precise control of hormone release:
Process Retraction: In response to neural signals (depolarization, calcium influx), pituicyte processes retract, increasing the surface area of direct terminal-vascular contact and facilitating hormone release into the capillary plexus.
Process Extension: During basal or inhibitory conditions, pituicyte processes extend to ensheath terminals more completely, limiting diffusion and reducing release.
Extracellular Space Modulation: Pituicytes actively regulate the extracellular volume fraction surrounding terminals through osmotic water flux via AQP4, thereby influencing the diffusion environment for hormone release[6].
The hypothalamic-pituitary axis undergoes significant alterations in Alzheimer's disease, with pituicytes playing contributing roles:
Oxytocin System Dysfunction
Vasopressin Changes
HPA Axis Abnormalities
Neuroendocrine Alterations
Autonomic Complications
Aging-Related Changes
Glial-Neuronal Communication
Oxytocin-Based Therapies
Vasopressin Modulation
Regenerative Approaches
The study of Pituicytes has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Theodosis DT, et al. "Glial cells in neuroendocrine systems: One hundred years of following the fortunes of neurosecretory cells." Progress in Brain Research. 2008;169:129-141. https://doi.org/10.1016/S0079-6123(07)00009-2 ↩︎
Hatton GI. "Function-related plasticity in hypothalamus." Annual Review of Neuroscience. 2004;27:369-395. https://doi.org/10.1146/annurev.neuro.27.070203.144206 ↩︎
Oliet SH, et al. "Plasticity of the pituicyte response to changes in the activity of neurohypophyseal neurons." Journal of Neuroendocrinology. 2008;20(6):733-741. https://doi.org/10.1111/j.1365-2826.2008.01737.x ↩︎
Rodriguez EM, et al. "The hypothalamic median eminence and the、皮下 pituitary: Shared boundaries." Frontiers in Neuroanatomy. 2019;13:71. https://doi.org/10.3389/fnana.2019.00071 ↩︎
Parri R, et al. "Calcium signaling in glial cells." Neurochemical Research. 2011;36(8):1346-1358. https://doi.org/10.1007/s11064-011-0438-x ↩︎
Nagelhus EA, et al. "Aquaporin-4 in the central nervous system: Cellular and subcellular distribution and coexpression with KIR4.1." Neuroscientist. 2004;10(2):99-107. https://doi.org/10.1177/1073858403260854 ↩︎
Bartzokis G. "Alzheimer's disease as a neurovascular disorder: The importance of cellular-adhesion molecules in the amyloid clearance pathway." Progress in Molecular Biology and Translational Science. 2020;176:95-124. https://doi.org/10.1016/bs.pmbts.2020.09.003 ↩︎